Almirall, S.A. (BME:ALM)
Spain · Delayed Price · Currency is EUR 12.66
+0.10 (0.80%)
Oct 28, 2025, 1:37 PM CET
Almirall Market Cap
Almirall has a market cap or net worth of €2.7 billion as of October 28, 2025. Its market cap has increased by 37.96% in one year.
Market Cap
2.70B
Enterprise Value
2.76B
Revenue
1.05B
Ranking
n/a
PE Ratio
125.02
Stock Price
€12.66
Market Cap Chart
Since June 20, 2007, Almirall's market cap has increased from 2.37B to 2.70B, an increase of 13.76%. That is a compound annual growth rate of 0.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2025 | 2.70B | 53.46% |
| Dec 31, 2024 | 1.76B | -0.35% |
| Dec 29, 2023 | 1.76B | 7.51% |
| Dec 30, 2022 | 1.64B | -19.23% |
| Dec 30, 2021 | 2.03B | 4.44% |
| Dec 31, 2020 | 1.95B | -23.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.89B |
| Laboratorios Farmaceuticos Rovi | 3.29B |
| Faes Farma | 1.40B |
| Pharma Mar | 1.29B |
| Clínica Baviera | 722.75M |
| Atrys Health | 256.45M |
| Oryzon Genomics | 252.72M |
| Laboratorio Reig Jofre | 241.73M |